DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Pediatrics
SEARCH
Current Location:
>
>
> This Story

Forward Printable StoryPrint Comment
advertisement

 

advertisement

 

Molecular Imaging Homepage

Scientists discover new method for developing tracers used for medical imaging

Radiology's role in determining the impact of Amyloid PET imaging on real-world Alzheimer's disease and dementia care

European Radiology profiles Seno Medical's breast cancer diagnostic technology

Jubilant Pharma announces formation of a new business focused on improving lives through nuclear medicine

Sofie expands its network by acquiring Cyclotope Radiopharmacy from Houston Cyclotron Partners

Keynote speakers for the opening day of its annual scientific session this September in Chicago

ANSTO new state-of-the-art nuclear medicine facility gets license

New radiotracer can identify nearly 30 types of cancer

United Imaging announces first U.S. clinical installation of uMI 550 DIGITAL PET/CT System

BGN Technologies introduces novel radioisotope production method for nuclear medicine used in imaging

Eden Radioisotopes secures reactor project funding for medical isotope production

Press releases may be edited for formatting or style
ALBUQUERQUE, N.M., May 22, 2019 /PRNewswire/ -- Eden Radioisotopes, LLC, an Albuquerque, NM startup company, is pleased to announce an investment agreement with Abo Empire, LLC, a Yates Family company. This investment funds the company project to build a reactor of less than 2MW in New Mexico for the purpose of producing medical isotopes, primarily Molybdenum-99. Known as Moly-99 for short, this isotope is a critical raw material for Technetium-99m, used extensively in medical molecular imaging, also known as nuclear medicine, around the world.

"We're thrilled to back the Eden team in their mission to provide the world with a dependable supply of Moly-99," says Ryan Price, Vice President of Abo Empire. "This project checks many boxes for us: it diversifies family investment through the economic development of the State of New Mexico, creates high-paying, highly technical jobs for our youth to grow into, and does a lot of good for a lot of people."

Story Continues Below Advertisement

Servicing GE Nuclear Medicine equipment with OEM trained engineers

We offer full service contracts, PM contracts, rapid response, time and material,camera relocation. Nuclear medicine equipment service provider since 1975. Click or call now for more information 800 96 NUMED



"Molecular Imaging is a $4 billion a year global market," says Chris Wagner, Eden's Chief Operating Officer and former Vice President at both Nordion and Mallinckrodt (n/k/a Curium). "There are 40 million diagnostic molecular imaging procedures performed worldwide each year, of which 80 percent use Technetium-99m, with 90 percent of those being either cardiac or cancer-related. While the imaging procedures performed in the United States represent more than half of the global use of Moly-99, there is no domestic supplier and no readily available alternative for molecular imaging. Reliability of Moly-99 supply is vitally important to US healthcare."

Moly-99 is used by radiopharmaceutical manufacturers worldwide to produce Molybdenum-99/Technetium-99m Generators, which are then shipped to hospitals, clinics, and radiopharmacies. As Moly-99 decays to Technetium-99m, it is then used to make individual patient doses for a variety of diagnostic imaging procedures.

For the past 20 years, the global supply of Moly-99 has been precarious at best. Only five reactors around the world have borne primary responsibility for Moly-99 production; in Canada, The Netherlands, South Africa, Belgium, and Australia. Due to age, these reactors have experienced numerous unplanned outages for repairs, causing shortages and price spikes. The Canadian reactor has already begun the decommissioning process, while the Dutch reactor is almost 60 years old and could soon be reaching the end of its useful life. "Together they represent more than 60 percent of the global supply capacity of Moly-99. With the Canadian reactor now offline, should The Netherlands reactor ever incur a long-term outage before sufficient new replacement capacity becomes available, the molecular imaging industry could experience challenging global supply shortages," says Wagner.
  Pages: 1 - 2 - 3 >>

Molecular Imaging Homepage


You Must Be Logged In To Post A Comment

Advertise
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Directory
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Requests
Gold Service Dealer Program
Receive RFP/PS
Requests
Healthcare Providers
See all
HCP Tools
Jobs/Training
Find/Fill
A Job
Parts Hunter +EasyPay
Get Parts
Quotes
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Quotes
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2019 DOTmed.com, Inc.
ALL RIGHTS RESERVED